NCT06870461

Brief Summary

This study aims to establish a registry for liver surgery and ablation procedures to improve patient care, advance research, and enhance surgical quality. The registry will collect pseudonymized data on patient demographics, disease characteristics, procedural details, and outcomes.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
167mo left

Started Apr 2025

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Apr 2025Jan 2040

First Submitted

Initial submission to the registry

December 18, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 11, 2025

Completed
21 days until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
9.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2035

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2040

Last Updated

March 11, 2025

Status Verified

March 1, 2024

Enrollment Period

9.8 years

First QC Date

December 18, 2024

Last Update Submit

March 5, 2025

Conditions

Malignant Liver TumorBenign Liver Tumor

Outcome Measures

Primary Outcomes (1)

  • Establishment of a Liver Surgery and Ablation Registry

    The primary objective of this study is to create a comprehensive registry of patients who have undergone liver surgery or liver ablation. This registry will serve as a foundation for future epidemiological studies, enabling the assessment of long-term outcomes, the identification of risk factors, and the evaluation of potential therapeutic interventions. Data collected will include demographic information, medical history, surgical details, postoperative outcomes, and survival rates. By compiling this data, we aim to better understand the patient population and improve care for individuals undergoing liver surgery or ablation.

    10 years

Interventions

Liver surgery / ablationPROCEDURE

Any type of liversurgery or CT-guidede liver ablation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who will undergo liver surgery or ablation.

You may qualify if:

  • Both benign and malignant liver lesions are included

You may not qualify if:

  • \- Intervention performed solely for liver biopsy, without any subsequent surgical resection or ablation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Carcinoma, Hepatocellular

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsLiver NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesLiver Diseases

Study Officials

  • Thiery Chapelle

    University Hospital, Antwerp

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bart Hendrikx

CONTACT

+3238214327hepatobiliaireheelkunde@uza.be

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2024

First Posted

March 11, 2025

Study Start

April 1, 2025

Primary Completion (Estimated)

January 1, 2035

Study Completion (Estimated)

January 1, 2040

Last Updated

March 11, 2025

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share